Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.

D-0006-2026

September 16, 2025

Class II

Product summary

Firm
ACCORD HEALTHCARE, INC.
Event
Event 97613
Status
Ongoing
Classification
Class II
Quantity
54,432 bottles
Official record key
drug-enforcement:D-0006-2026

Official wording

Reason: Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Code information: Lot # D2300045, Exp 12/31/2025.

Distribution pattern: Nationwide in the US

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent